ALINA: efficacy and safety of adjuvant alectinib versus chemotherapy in patients with early-stage ALK plus non-small cell lung cancer (NSCLC)

被引：0

作者：

Shah, Rajiv ^{[1
,2
]}

Solomon, Benjamin J. ^{[3
]}

Ahn, Jin Seok ^{[4
]}

Dziadziuszko, Rafal ^{[5
,6
]}

Barlesi, Fabrice ^{[7
]}

Nishio, Makoto ^{[8
]}

Lee, Dae Ho ^{[9
]}

Lee, Jong-Seok ^{[10
]}

Zhong, Wenzhao ^{[11
]}

Horinouchi, Hidehito ^{[12
]}

Mao, Weimin ^{[13
]}

Hochmair, Maximilian ^{[14
]}

de Marinis, Filippo ^{[15
]}

Migliorino, Maria Rita ^{[16
]}

Bondarenko, Igor ^{[17
]}

Lohmann, Tania Ochi ^{[18
]}

Xu, Tingting ^{[19
]}

Cardona, Andres ^{[20
]}

Bordogna, Walter ^{[21
]}

Ruf, Thorsten ^{[22
]}

Wu, Yi-Long ^{[11
]}

机构：

[1] Heidelberg Univ Hosp, Dept Thorac Oncol, Thoraxklin, Heidelberg, Germany

[2] NCT Heidelberg, Translat Lung Res Ctr Heidelberg TLRC H, Natl Ctr Tumor Dis NCT, Heidelberg, Germany

[3] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Australia

[4] Samsung Med Ctr, Dept Hematol & Oncol, Seoul, South Korea

[5] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland

[6] Med Univ Gdansk, Early Phase Clin Trials Ctr, Gdansk, Poland

[7] Saclay Univ, Dept Med Oncol, Int Ctr Thorac Canc CICT, Gustave Roussy,Fac Med, Le Kremlin Bicetre, France

[8] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan

[9] Asan Med Ctr, Dept Oncol, Seoul, South Korea

[10] Seoul Natl Univ, Div Hematol & Med Oncol, Dept Internal Med, Bundang Hosp, Seongnam, South Korea

[11] Southern Med Univ, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangzhou, Peoples R China

[12] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan

[13] Chinese Acad Sci, Inst Basic Med & Canc, Hangzhou, Zhejiang, Peoples R China

[14] Klin Floridsdorf, Dept Resp & Crit Care Med, Karl Landsteiner Inst Lung Res & Pulm Oncol, Vienna, Austria

[15] European Inst Oncol IRCSS, Thorac Oncol Div, Milan, Italy

[16] San Camillo Forlanini Hosp, Pneumooncol Unit, Rome, Italy

[17] Dnipropetrovsk Med Acad, Oncol & Med Radiol Dept, Dnipro, Ukraine

[18] F Hoffmann La Roche Ltd, PD Oncol, Basel, Switzerland

[19] Roche China Holding Ltd, Dept Clin Sci, Shanghai, Peoples R China

[20] F Hoffmann La Roche Ltd, Data & Stat Sci, Basel, Switzerland

[21] F Hoffmann La Roche Ltd, Prod Dev Med Affairs, Basel, Switzerland

[22] F Hoffmann La Roche Ltd, PD Safety Risk Management, Basel, Switzerland

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1018

引用

页码：243 / 244

页数：2

共 50 条

[21] Adjuvant chemotherapy for early stage non-small cell lung cancer
Patel, Manali L.
Wakelee, Heather A.
FRONTIERS IN ONCOLOGY, 2011, 1
[22] Adjuvant Therapy in Early-Stage Non-Small Cell Lung Cancer
Serke, Monika
CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 135 - 144
[23] Efficacy and safety of thoracoscopic resection for early-stage non-small cell lung cancer
Cao, Peng
Yue, Jiaqi
Hu, Shan
Kong, Kangle
Han, Peng
Yang, Ziheng
Deng, Yu
Li, Fan
Zhao, Bo
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (06): : 4024 - 4032
[24] Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non-Small-Cell Lung Cancer
Felip, Enriqueta
Rosell, Rafael
Antonio Maestre, Jose
Manuel Rodriguez-Paniagua, Jose
Moran, Teresa
Astudillo, Julio
Alonso, Guillermo
Manuel Borro, Jose
Luis Gonzalez-Larriba, Jose
Torres, Antonio
Camps, Carlos
Guijarro, Ricardo
Isla, Dolores
Aguilo, Rafael
Alberola, Vicente
Padilla, Jose
Sanchez-Palencia, Abel
Javier Sanchez, Jose
Hermosilla, Eduardo
Massuti, Bartomeu
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) : 3138 - 3145
[25] Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis
Wood, Cameron
Lyniv, Liliana
Isaacs, James M.
Kaufman, Jacob M.
Oduah, Eziafa, I
Clarke, Jeff
Crawford, Jeffrey
Stinchcombe, Thomas
Tong, Betty C.
Wang, Xiaofei
Gu, Lin
Wigle, Dennis
Dragnev, Konstantin H.
Antonia, Scott J.
Weinhold, Kent
Ready, Neal
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)
[26] Adjuvant chemotherapy in non-small cell lung cancer (NSCLC)
Felip, E.
Cedres, S.
Peralta, S.
Prat, A.
ANNALS OF ONCOLOGY, 2007, 18 : 143 - 146
[27] Neoadjuvant chemotherapy in early-stage non-small cell lung cancer
Salva, Francesc
Felip, Enriqueta
TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (05) : 398 - 402
[28] Adjuvant or neoadjuvant chemotherapy in early-stage non-small cell lung cancer (NSCLC): How would staging affect the patients (pts) treated?
Van Meerbeeck, J. P.
Nicholson, M.
Gilligan, D.
Groen, H. J.
Nankivell, M.
Pugh, C.
Stephens, R.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[29] Changes in chemotherapy uptake and wait times in early-stage non-small cell lung cancer (NSCLC)
Gray, S. L.
Bu, J.
Saint-Jacques, N.
Rayson, D.
Younis, T.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[30] Waiting times in early-stage non-small cell lung cancer (NSCLC)
Saint-Jacques, Nathalie
Rayson, Daniel
Al-Fayea, Turki
Virik, Kiran
Morzycki, Wojciech
Younis, Tallal
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) : 865 - 870

← 1 2 3 4 5 →